ATE122654T1 - Behandlung von hiv-infizierungen und nützliche verbindungen dafür. - Google Patents

Behandlung von hiv-infizierungen und nützliche verbindungen dafür.

Info

Publication number: ATE122654T1
Authority: AT; Austria
Prior art keywords: treatment; useful compounds; hiv infections; compounds; disclosed
Prior art date: 1989-10-16

Application number

AT90915588T

Other languages

English (en)

Inventor

William A Harrison

Gary E Jewell

Ethel E Felauer

Mark A Dekeyser

Dong D Cong

James A Mcguiness

Anupama Mishra

Walter G Brouwer

Derek J Mcphee

Original Assignee

Uniroyal Chemical Ltd

Uniroyal Chem Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-10-16

Filing date

1990-10-09

Publication date

1995-06-15

1990-10-09 Application filed by Uniroyal Chemical Ltd, Uniroyal Chem Co Inc filed Critical Uniroyal Chemical Ltd

1995-06-15 Application granted granted Critical

1995-06-15 Publication of ATE122654T1 publication Critical patent/ATE122654T1/de

Links

150000001875 compounds Chemical class 0.000 title abstract 4
208000031886 HIV Infections Diseases 0.000 title 1
238000000034 method Methods 0.000 abstract 3
241000700605 Viruses Species 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000010076 replication Effects 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/55—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an unsaturated carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C271/38—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/22—Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D305/06—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
- C07F9/2475—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aralkylamines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Pyrane Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pyrrole Compounds (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Furan Compounds (AREA)

AT90915588T 1989-10-16 1990-10-09 Behandlung von hiv-infizierungen und nützliche verbindungen dafür. ATE122654T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US42115589A	1989-10-16	1989-10-16
US56798290A	1990-08-15	1990-08-15
US07/588,208 US5268389A (en)	1989-10-16	1990-09-26	Thiocarboxylate ester compounds compositions containing the same

Publications (1)

Publication Number	Publication Date
ATE122654T1 true ATE122654T1 (de)	1995-06-15

Family

ID=27411301

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90915588T ATE122654T1 (de)	1989-10-16	1990-10-09	Behandlung von hiv-infizierungen und nützliche verbindungen dafür.

Country Status (16)

Country	Link
US (2)	US5268389A (de)
EP (1)	EP0497816B1 (de)
JP (1)	JPH06102641B2 (de)
KR (1)	KR100222233B1 (de)
CN (1)	CN1051036A (de)
AT (1)	ATE122654T1 (de)
AU (1)	AU636409B2 (de)
BR (1)	BR9007758A (de)
CA (1)	CA2067381C (de)
DE (1)	DE69019533T2 (de)
DK (1)	DK0497816T3 (de)
GR (1)	GR3017128T3 (de)
HU (1)	HU220759B1 (de)
IL (1)	IL95956A (de)
RU (1)	RU2108785C1 (de)
WO (1)	WO1991005761A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5146321A (en) *	1991-06-12	1992-09-08	Eastman Kodak Company	Linear film scanner operable at different line rates
WO1993005020A1 (en) *	1991-09-06	1993-03-18	Merck & Co., Inc.	Indoles as inhibitors of hiv reverse transcriptase
US5527819A (en) *	1991-09-06	1996-06-18	Merck & Co., Inc.	Inhibitors of HIV reverse transcriptase
BR9405737A (pt) *	1993-02-24	1995-12-05	Merck & Co Inc	Composto processo de inibição de transcriptase reserva de HIV, processo de prevenção contra a infecção pelo HIV ou de tratamento da infecção pelo HIV, composição farmacêutica útil para a inibição da transcriptase reserva de HIV, e, útil para a prevenção ou tratamento de infecção pelo HIV ou para o tratamento da AIDS ou ARC
US5968910A (en) *	1994-11-30	1999-10-19	Jan M. R. Balzarini	Compositions containing two or three inhibitors of different HIV reverse transcriptases
US5550280A (en) *	1994-11-30	1996-08-27	Uniroyal Chemical Ltd./ Uniroyal Chemical Ltee	Hindered aromatic ester compounds useful as anti-viral agents
US5663199A (en) *	1994-11-30	1997-09-02	Uniroyal Chemical Ltd./Ltee	Anti-viral aromatic O-alkylated oximes, ethers and thioethers
US5580544A (en) *	1995-03-29	1996-12-03	Uniroyal Chemical Company, Inc.	Paste formulation useful for seed treatment and foliar treatment of plants
US5696151A (en) *	1995-11-30	1997-12-09	Uniroyal Chemical Company, Inc.	Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants
US6498265B2 (en)	1995-12-21	2002-12-24	Syngenta Investment Corporation	3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation
US5847147A (en) *	1996-12-20	1998-12-08	Novartis Corp.	3-Amino-2-mercaptobenzoic acid derivatives and processes for their preparation
US5914351A (en) *	1997-12-12	1999-06-22	Uniroyal Chemical Company, Inc.	Anti-viral aromatic hydrazones
WO1999065871A2 (en) *	1998-06-19	1999-12-23	The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services	Thiolesters and uses thereof
DK1112743T3 (da) *	1998-08-20	2007-11-26	Toyama Chemical Co Ltd	Nitrogenholdige heterocykliske carboxamidderivater eller salte deraf som antivirale midler
PT1165494E (pt) *	1999-03-25	2004-03-31	Boehringer Ingelheim Ca Ltd	Inibidores da primase do vhs
WO2002012189A1 (en) *	2000-08-09	2002-02-14	Mitsubishi Pharma Corporation	Fused bicyclic amide compounds and medicinal use thereof
MXPA04001253A (es) *	2001-08-09	2004-06-03	Ono Pharmaceutical Co	Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo.
US7064139B2 (en) *	2001-10-29	2006-06-20	Uniroyal Chemical Company, Inc.	Method for treating retroviral infections
US6498254B1 (en) *	2001-10-29	2002-12-24	Uniroyal Chemical Company, Inc.	Antiretroviral compounds and compositions
CN1652759A (zh) *	2002-03-11	2005-08-10	泰博特克药品有限公司	小分子进入抑制剂
CN1738797A (zh)	2002-11-19	2006-02-22	阿基里昂药品公司	取代的芳基硫脲和相关的化合物,病毒复制的抑制剂
WO2007052843A1 (ja) *	2005-11-04	2007-05-10	Takeda Pharmaceutical Company Limited	複素環アミド化合物およびその用途
KR20120099473A (ko) *	2009-12-01	2012-09-10	세프록스 바이오텍, 에스.엘.	Ｈｉｖ 감염 예방을 위한 히드록시타이로졸 및 유도체의 국소적 사용
CN113754613B (zh) *	2021-09-27	2023-06-30	北京工商大学	一种4-烯醇的苯硫基环醚化方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3249499A (en)	1965-04-26	1966-05-03	Us Rubber Co	Control of plant diseases
NL134133C (de)	1965-11-05
US3454391A (en)	1966-05-04	1969-07-08	Uniroyal Inc	Stimulation of plant growth
US3657449A (en)	1970-03-09	1972-04-18	Uniroyal Inc	Control of virus diseases of plants with carboxamido oxathins
US3806332A (en)	1970-03-09	1974-04-23	Uniroyal Ltd	Plant air pollution protectants
FR2143577A1 (en) *	1971-06-30	1973-02-09	Ugine Kuhlmann	3-(2-chlorobenzamido)benzoic acids and salts - with uricosuric activity
IL46853A0 (en) *	1974-03-20	1975-05-22	Bayer Ag	Novel alkoxycarbonylphenylureas,their preparation and their use as herbicides
US4004018A (en)	1974-06-20	1977-01-18	Uniroyal Inc.	2,3-Dihydro-1,4-dithiin 1,1,4,4-tetroxide antimicrobials
US4197124A (en) *	1975-07-29	1980-04-08	Fuji Photo Film Co., Ltd.	Non-treatment type planographic printing plate materials
CA1124248A (en)	1978-08-27	1982-05-25	Andrew A. Znotins	Method of making 5,6-dihydro-2-methyl-n-phenyl-1,4- oxathiin-3-carboxamide
US4182716A (en)	1978-09-05	1980-01-08	Uniroyal, Ltd.	Method of making 5,6-dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide
CA1166262A (en)	1981-08-11	1984-04-24	Frederick M.M. Hager	Synthesis of intermediate for the manufacture of 5,6- dihydro-2-methyl-n-phenyl-1,4-oxathiin-3-carboxamide
IE56108B1 (en) *	1982-07-16	1991-04-24	Carpibem	1-(2-carbalkoxy-4-(thienylcarboxamido)phenoxy)-3-amino 2-propanols,their preparation and applications thereof in therapeutics
FR2530245A1 (fr) *	1982-07-16	1984-01-20	Carpibem	Nouveaux 1-(2-carbalkoxy 4-(thienyl-alkylamido)phenoxy) 3-amino 2-propanols, leur preparation et leurs applications en therapeutique
ES8600233A1 (es) *	1982-09-16	1985-09-16	Sumitomo Chemical Co	Un procedimiento para producir una n-fenilcarbamato.
JPS5951258A (ja) *	1982-09-16	1984-03-24	Sumitomo Chem Co Ltd	Ｎ−フエニルチオカ−バメ−ト系化合物、その製造法およびそれを有効成分とする農園芸用殺菌剤
FR2555179B1 (fr) *	1983-11-21	1986-11-21	Carpibem	Nouveaux (carbethoxy-2 furyl- ou benzofuryl-carboxamido-4 phenoxy)-1 amino-3 propanols-2 : leurs preparations et leurs applications en therapeutique
WO1987001284A1 (en) *	1985-08-26	1987-03-12	United States Of America, Represented By The Unite	Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
DE3534440A1 (de) *	1985-09-27	1987-04-02	Hoechst Ag	Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US4880782A (en) *	1986-11-21	1989-11-14	Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V.	Method of treating viral infections in humans and compositions therefor
IT1222142B (it) *	1987-07-27	1990-09-05	Adolfo Turano	Composizioni farmaceutiche antivirali
US4980371A (en) *	1988-12-21	1990-12-25	Merrell Dow Pharmaceuticals	Antiretroviral furan ketones

1990
- 1990-09-26 US US07/588,208 patent/US5268389A/en not_active Expired - Lifetime
- 1990-10-09 KR KR1019920700831A patent/KR100222233B1/ko not_active Expired - Lifetime
- 1990-10-09 JP JP2514569A patent/JPH06102641B2/ja not_active Expired - Fee Related
- 1990-10-09 AU AU66035/90A patent/AU636409B2/en not_active Ceased
- 1990-10-09 HU HU9201258A patent/HU220759B1/hu unknown
- 1990-10-09 DE DE69019533T patent/DE69019533T2/de not_active Expired - Fee Related
- 1990-10-09 RU SU5011885A patent/RU2108785C1/ru not_active IP Right Cessation
- 1990-10-09 CA CA002067381A patent/CA2067381C/en not_active Expired - Fee Related
- 1990-10-09 AT AT90915588T patent/ATE122654T1/de not_active IP Right Cessation
- 1990-10-09 EP EP90915588A patent/EP0497816B1/de not_active Expired - Lifetime
- 1990-10-09 DK DK90915588.9T patent/DK0497816T3/da active
- 1990-10-09 WO PCT/US1990/005760 patent/WO1991005761A1/en not_active Ceased
- 1990-10-09 BR BR909007758A patent/BR9007758A/pt not_active Application Discontinuation
- 1990-10-10 IL IL9595690A patent/IL95956A/en not_active IP Right Cessation
- 1990-10-16 CN CN90108426A patent/CN1051036A/zh active Pending
1995
- 1995-06-07 US US08/485,291 patent/US5693827A/en not_active Expired - Lifetime
- 1995-08-16 GR GR950402247T patent/GR3017128T3/el unknown

Also Published As

Publication number	Publication date
JPH06102641B2 (ja)	1994-12-14
RU2108785C1 (ru)	1998-04-20
US5693827A (en)	1997-12-02
US5268389A (en)	1993-12-07
EP0497816A1 (de)	1992-08-12
KR100222233B1 (ko)	1999-10-01
HU220759B1 (hu)	2002-05-28
KR920703049A (ko)	1992-12-17
EP0497816B1 (de)	1995-05-17
DK0497816T3 (da)	1995-10-09
BR9007758A (pt)	1992-08-11
WO1991005761A1 (en)	1991-05-02
DE69019533T2 (de)	1995-10-26
HUT60713A (en)	1992-10-28
AU6603590A (en)	1991-05-16
AU636409B2 (en)	1993-04-29
IL95956A0 (en)	1991-07-18
HU9201258D0 (en)	1992-07-28
CN1051036A (zh)	1991-05-01
IL95956A (en)	1996-03-31
CA2067381A1 (en)	1991-04-17
GR3017128T3 (en)	1995-11-30
DE69019533D1 (de)	1995-06-22
CA2067381C (en)	2004-04-06
JPH04507422A (ja)	1992-12-24

Legal Events

Date	Code	Title
1995-11-15	UEP	Publication of translation of european patent specification
1999-05-15	EEIH	Change in the person of patent owner
2009-07-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69019533D1 (de)	1995-06-22	Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
MD1507G2 (ro)	2001-04-30	Inhibitori, compoziţie farmaceutică pe baza lor şi procedeu de inhibare a HIV proteazei
HUP0101999A2 (hu)	2001-11-28	4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
RU95106823A (ru)	1996-11-20	Сукциноиламиногидроксиэтиламиносульфонамиды, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции способ лечения спида
ATE130514T1 (de)	1995-12-15	Verwendung von stickstoff enthaltenden makrozyklen zur behandlung retroviraler infektionen.
ES2051641A1 (es)	1994-06-16	Procedimientos para la preparacion de compuestos derivados de tiourea.
IL111674A0 (en)	1995-01-24	5,6-Dihydropyrone derivatives and pharmaceutical compositions containing them
DE69323183D1 (de)	1999-03-04	Weitere indolderivate mit antiviraler wirkung
DK0604183T3 (da)	1997-05-26	HIV-protease-inhibitorer anvendelige i behandlingen af AIDS
FI962488A0 (fi)	1996-06-14	HIV:n proteaasin inhibiittoreita
IL111673A0 (en)	1995-01-24	5,6-Dihydropyrone derivatives and pharmaceutical compositions containing them
TNSN89039A1 (fr)	1991-02-04	Tetrahydroimidazo(1,4)benzodiazepin-2-ones antivirales
DE69127976D1 (de)	1997-11-20	Tropolonderivate und pharmazeutische zubereitungen davon zur vorbeugung und behandlung von ischämischen krankheiten
ATE179164T1 (de)	1999-05-15	Hiv-proteaseinhibitoren
ATE148109T1 (de)	1997-02-15	Hiv-proteaseinhibitoren und ihre verwendung zur behandlung von aids
DE69232417D1 (de)	2002-03-21	Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren
DE69019404D1 (de)	1995-06-22	Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
RU94000064A (ru)	1996-07-10	Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции
MD1687F2 (en)	2001-06-30	Arylthiocompounds, pharmaceutical composition, methods of bacterial and viral infections treatment
UA42693C2 (uk)	2001-11-15	Лікарський засіб для лікування інфекції лентивірусом, препарат для лікування людини, яка інфікована лентивірусом
RU93058386A (ru)	1996-10-10	Противовирусная комбинация, содержащая неуклеозидный аналог, фармацевтическая композиция, способ лечения
KR940703656A (ko)	1994-12-12	에이즈 바이러스 감염 저해용 조성물
RU93055683A (ru)	1996-12-27	Ингибиторы вич-протеазы, способ их получения, их использование, композиция
ATE210985T1 (de)	2002-01-15	Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
ATE198272T1 (de)	2001-01-15	Antivirale zusammensetzungen, die eine kombination eines dimethylbenzylalkylammoniumiodides mit einem amidoalkylammoniumiodid enthalten